Learning Objectives:

1.         Epidemiology of APOL1 mediated kidney disease and distribution of APOL 1 HR variants

2.         Mechanism of APOL1 risk mediated kidney disease

3.         Application of APOL1 testing in clinical practice

Session date: 
03/14/2024 - 4:00pm to 5:00pm CDT
Location: 
Via Zoom
5841 S. Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Mohammed A. Rafey, MD MS